🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
Currently, for further improved survival outcome, new cytotoxic compounds s...
Status
Completed
Location
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Start Date
2013-07
Trial ID
NCT02495493
Treatments Being Tested
This is a global, multicenter, randomized, open-label, Phase 2/3 study of D...
Status
Recruiting
Location
Research Site
Start Date
2025-09-26
Trial ID
NCT07129993
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Institut Jules Bordet
Start Date
1999-07
Trial ID
NCT00004884
Treatments Being Tested
This is a single arm Phase II study, in which 6 cycles of durvalumab with c...
Status
Unknown
Location
Beijing Haidian Hospital
Start Date
2021-09-01
Trial ID
NCT05034133
Treatments Being Tested
RATIONALE: Patient abstract not available PURPOSE: Patient abstract not av...
Status
Completed
Location
NYU School of Medicine's Kaplan Comprehensive Cancer Center
Start Date
1998-09
Trial ID
NCT00004033
Treatments Being Tested
This is a Phase I Clinical Trial. Phase I studies are designed to determine...
Status
Terminated
Location
University of Maryland Greenebaum Cancer Center
Start Date
2010-04-27
Trial ID
NCT01110226
This study is a card Rayleigh bead single combined cisplatin treatment of a...
Status
Unknown
Location
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Start Date
2022-08-05
Trial ID
NCT05490485
Treatments Being Tested
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955